Exiqon Releases Second Generation Human and Mouse microRNA Inhibitor Libraries
January 12, 2011
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 2nd generation of miRCURY LNA™ microRNA Inhibitor libraries for genome-wide screening of microRNA function in human and mouse. Several libraries have already been shipped to the first customers. The new human microRNA inhibitor library targets [...]
FDA Awards SDIX Method Equivalency for Salmonella Enteritidis Detection in Poultry Houses and Eggs
January 12, 2011
NEWARK, Del.--SDIX™ (NASDAQ: SDIX), a leading supplier of rapid detection solutions to the $1 billion food pathogen testing market, today announced that its RapidChek® SELECT™ Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard [...]
Thermo Fisher Scientific Responds to Dioxin Food Safety Crisis in Germany
January 12, 2011
DREIEICH, Germany. – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Global Food Safety Response Center in Dreieich is now monitoring the dioxin crisis in Germany where animal feed additives may have been tainted with industrial fats containing the toxic chemical. Meanwhile, Thermo Fisher is also alerting manufacturers and [...]
Sub 60-Second Identification of MRSA and Other Hospital Acquired Infections Demonstrated
January 11, 2011
Andor iStar camera validates potential for new generation of rapid, automated biosensor detection systems Belfast, UK: At a time of rising levels of MRSA and other hospital acquired infections, Laser Induced Breakdown Spectroscopy (LIBS) has been demonstrated to be a rapid and reliable technique for detection of life-threatening bacterial pathogen species that can be found [...]
Illumina Announces Preliminary Financial Results for Fourth Quarter 2010
January 11, 2011
Company Provides Guidance for 2011 SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced preliminary revenue for the fourth quarter of 2010 of approximately $260 million. This implies fiscal year 2010 revenue of approximately $901 million or annual growth of 35%. The company also announced preliminary non-GAAP earnings per share for the fourth quarter and fiscal [...]
IDEX Corporation Signs Agreement to Acquire Microfluidics International Corporation
January 11, 2011
LAKE FOREST, Ill. & NEWTON, Mass. - IDEX Corporation (NYSE: IEX) today announced that it has entered into a definitive merger agreement to acquire Microfluidics International Corporation (OTC Bulletin Board: MFLU) for $1.35 per share, net to the seller in cash, and subject to adjustment as provided in the merger agreement. The transaction is expected [...]
Agilent SureSelect XT Workflow
January 11, 2011
An Integrated Workstation for High-Throughput Target Enrichment Integrating advanced automation, liquid handling with Agilent SureSelect XT workflow - Agilent Automation Solutions has created a fully optimized and validated high throughput target enrichment solution. SureSelect XT combines next generation sequencing library preparation and gDNA preparative reagents with the proven SureSelect target enrichment system. This, together with [...]
SeqWright Continues Expansion of Next-Generation Sequencing Capabilities
January 11, 2011
HOUSTON - SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, continues to make significant strides to position itself as the Next-Generation Sequencing Provider of choice for 2011. SeqWright's ongoing success can be attributed to the company’s ability to respond quickly to customer’s demands and by investing in key genomics technologies. Building [...]
Life Technologies Makes DNA Sequencing More Accessible to Laboratories of All Sizes Around the World
January 11, 2011
New Innovations Lower Costs and Simplify Workflows CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced a series of new product innovations across the company’s DNA sequencing portfolio. To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies. [...]
Expression Pathology provides Roche its Liquid Tissue®-SRM Protein
January 11, 2011
Biomarker Assay Services in Drug Development Rockville, MD - Expression Pathology Inc. announced an agreement with Roche (SIX:RO, ROG; OTCQX:RHHBY) wherein Expression Pathology will provide its Liquid Tissue®- SRM Technology to accelerate identification of cancer molecular markers for developing more effective treatments. Under the terms of the agreement, Expression Pathology will support Roche oncology drug [...]
